You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MGMT-Unmethylated Glioblastoma

Showing 1 - 25 of 1,216
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma Trial (Azeliragon)

Not yet recruiting
  • Glioblastoma
  • (no location specified)
Aug 3, 2023

MGMT-Unmethylated Glioblastoma Trial (Etoposide Plus Cisplatin)

Not yet recruiting
  • MGMT-Unmethylated Glioblastoma
  • Etoposide Plus Cisplatin
  • (no location specified)
Jan 12, 2023

MGMT-unmethylated Glioblastoma (GBM), GBM Trial in New York (Nivolumab, Ipilimumab, Radiation Therapy (RT))

Completed
Has Results
  • MGMT-unmethylated Glioblastoma (GBM)
  • GBM
  • New York, New York
    New York University School of Medicine
Jun 30, 2022

Newly Diagnosed MGMT Unmethylated Glioblastoma Trial in Durham (D2C7-IT, 2141-V11)

Not yet recruiting
  • Newly Diagnosed MGMT Unmethylated Glioblastoma
  • Durham, North Carolina
    Duke University Medical Center
Feb 7, 2023

Glioblastoma Trial (Dose escalation of radiation dose beyond the therapeutic standard)

Not yet recruiting
  • Glioblastoma
  • Dose escalation of radiation dose beyond the therapeutic standard
  • (no location specified)
May 13, 2023

Advanced Glioblastoma, Metastatic Melanoma in the CNS, MGMT-Unmethylated Glioblastoma Trial in Ramat Gan (Crizanlizumab-Tmca 10

Not yet recruiting
  • Advanced Glioblastoma
  • +2 more
  • Crizanlizumab-Tmca 10 MG/1 ML Intravenous Solution [ADAKVEO]
  • Nivolumab 10 MG/1 ML Intravenous Solution [OPDIVO]
  • Ramat Gan, Israel
    Sheba medical center
Jun 11, 2023

Glioblastoma, Gliosarcoma Trial in Houston (drug, radiation, procedure)

Recruiting
  • Glioblastoma
  • Gliosarcoma
  • Houston, Texas
    M D Anderson Cancer Center
Sep 27, 2022

Glioblastoma Trial in Belgium, Germany, Netherlands (CV09050101 mRNA vaccine (CVGBM) 12 µg, CV09050101 mRNA vaccine (CVGBM) 25

Recruiting
  • Glioblastoma
  • CV09050101 mRNA vaccine (CVGBM) 12 μg
  • +5 more
  • Woluwe-Saint-Lambert, Brussels, Belgium
  • +14 more
Jul 12, 2023

MGMT-Unmethylated Glioblastoma Trial in Nanjing (Anlotinib, AK105, Radiotherapy)

Recruiting
  • MGMT-Unmethylated Glioblastoma
  • Nanjing, Jiangsu, China
    The Affiliated Nanjing Drum Tower Hospital of Nanjing University
Aug 27, 2021

Glioblastoma Trial in Gainesville (Ex-Vivo expanded autologous IL-8 receptor (CXCR2) modified CD70 CAR (8R-70CAR) T cells)

Not yet recruiting
  • Glioblastoma
  • Ex-Vivo expanded autologous IL-8 receptor (CXCR2) modified CD70 CAR (8R-70CAR) T cells
  • Gainesville, Florida
    University of Florida Health
Jul 29, 2022

Glioma, Glioblastoma, Glioblastoma Multiforme Trial in Houston (VAL-083, Dianhydrogalactitol)

Active, not recruiting
  • Glioma
  • +4 more
  • VAL-083, Dianhydrogalactitol
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 23, 2022

Astrocytoma, Glioblastoma, Glioblastoma, IDH-Wildtype Trial in Chicago (drug, other, radiation)

Recruiting
  • Astrocytoma
  • +4 more
  • Mycophenolate Mofetil
  • +3 more
  • Chicago, Illinois
    Northwestern University
Aug 22, 2022

Newly Diagnosed Glioblastoma Trial ([177Lu]Lu-NeoB, [68Ga]Ga-NeoB, Temozolomide)

Not yet recruiting
  • Newly Diagnosed Glioblastoma
  • (no location specified)
Feb 13, 2023

Glioblastoma Multiforme Trial in Barcelona, Madrid (Tinostamustine)

Recruiting
  • Glioblastoma Multiforme
  • Barcelona, Spain
  • +1 more
Jul 18, 2022

Glioma, Glioblastoma, Glioblastoma Multiforme Trial in Guangzhou (VAL-083 (Dianhydrogalactitol))

Active, not recruiting
  • Glioma
  • +4 more
  • VAL-083 (Dianhydrogalactitol)
  • Guangzhou, China
    Sun Yat-Sen University Cancer Center
Mar 23, 2022

Glioblastoma, Glioma, Malignant Trial in Durham (MT-201-GBM monocyte vaccine)

Not yet recruiting
  • Glioblastoma
  • Glioma, Malignant
  • MT-201-GBM monocyte vaccine
  • Durham, North Carolina
    The Preston Robert Tisch Brain Tumor Center at Duke University M
May 25, 2022

Glioblastoma Trial in Bergen, Oslo (Bortezomib and Temozolomide Phase IB, Bortezomib and Temozolomide Phase II)

Recruiting
  • Glioblastoma
  • Bortezomib and Temozolomide Phase IB
  • Bortezomib and Temozolomide Phase II
  • Bergen, Norway
  • +1 more
Aug 24, 2021

Glioblastoma Trial in Philadelphia (CART-EGFRvIII T cells, Pembrolizumab)

Completed
  • Glioblastoma
  • CART-EGFRvIII T cells
  • Pembrolizumab
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Mar 2, 2021

MGMT-Unmethylated Glioblastoma Trial in Hangzhou (Anlotinib)

Recruiting
  • MGMT-Unmethylated Glioblastoma
  • Hangzhou, Zhejiang, China
    The Second Affiliated Hospital of Zhejiang University School of
Jan 24, 2021

Glioblastoma Multiforme Trial in Milan, Rome (Temferon)

Recruiting
  • Glioblastoma Multiforme
  • Milan, Italy
  • +2 more
Feb 8, 2021

Glioblastoma Multiforme of Brain Trial (biological, procedure, radiation, drug)

Not yet recruiting
  • Glioblastoma Multiforme of Brain
  • TVI-Brain-1
  • +3 more
  • (no location specified)
Jan 13, 2023

Unmethylated Glioblastoma Trial in Saint Louis (Personalized Neoantigen DNA vaccine, Retifanlimab, TDS-IM v 2.0 electroporation

Not yet recruiting
  • Unmethylated Glioblastoma
  • Personalized Neoantigen DNA vaccine
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Feb 14, 2023

6 Months Adjuvant Temozolomide vs No Adjuvant TMZ in Newly

Withdrawn
  • MGMT-Methylated Glioblastoma
  • Delay of TMZ
  • Standard of Care (SOC) Adjuvant TMZ (no intervention
  • (no location specified)
Aug 5, 2022

Glioblastoma, IDH-wildtype, MGMT-Methylated Glioblastoma Trial in Padova (Regorafenib, Temozolomide)

Recruiting
  • Glioblastoma, IDH-wildtype
  • MGMT-Methylated Glioblastoma
  • Padova, Italy
    Istituto Oncologico Veneto IRCCS
Oct 18, 2023

Glioblastoma, Adult Trial in United States (Paxalisib (GDC-0084))

Active, not recruiting
  • Glioblastoma, Adult
  • Paxalisib (GDC-0084)
  • Los Angeles, California
  • +5 more
Aug 16, 2022